bioMérieux S.A. (BMXXY)
OTCMKTS · Delayed Price · Currency is USD
14.55
+1.95 (15.48%)
At close: Jan 14, 2026
bioMérieux Employees
As of December 31, 2024, bioMérieux had 14,754 total employees, including 14,147 full-time and 607 part-time employees. The number of employees increased by 772 or 5.52% compared to the previous year.
Employees
14,754
Change (1Y)
772
Growth (1Y)
5.52%
Revenue / Employee
$334,969
Profits / Employee
$30,711
Market Cap
13.02B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 14,754 | 772 | 5.52% | 14,147 | 607 |
| Dec 31, 2023 | 13,982 | 847 | 6.45% | 13,409 | 573 |
| Dec 31, 2022 | 13,135 | 756 | 6.11% | 12,557 | 578 |
| Dec 31, 2021 | 12,379 | -245 | -1.94% | 12,084 | 295 |
| Dec 31, 2020 | 12,624 | 624 | 5.20% | 12,317 | 307 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Centogene | 384 |
| Interpace Biosciences | 111 |
| Psychemedics | 101 |
| Aspira Women's Health | 66 |
| Longduoduo Company | 52 |
| Hypha Labs | 5 |
bioMérieux News
- 3 months ago - bioMérieux S.A. (BMXXY) Analyst/Investor Day Transcript - Seeking Alpha
- 5 months ago - BioMérieux S.A. (BMXXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - bioMérieux S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 1 year ago - bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript - Seeking Alpha
- 4 years ago - bioMérieux: Pioneering In Vitro Diagnostics - Seeking Alpha